Literature DB >> 10480922

Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication.

S Brown1, M J McGrath, L M Ooms, R Gurung, M M Maimone, C A Mitchell.   

Abstract

We have cloned and characterized a novel isoform of the skeletal muscle LIM protein 1 (SLIM1), designated SLIMMER. SLIM1 contains an N-terminal single zinc finger followed by four LIM domains. SLIMMER is identical to SLIM1 over the first three LIM domains but contains a novel C-terminal 96 amino acids with three potential bipartite nuclear localization signals, a putative nuclear export sequence, and 27 amino acids identical to the RBP-J binding region of KyoT2, a murine isoform of SLIM1. SLIM1 localized to the cytosol of Sol8 myoblasts and myotubes. SLIMMER was detected in the nucleus of myoblasts and, following differentiation into myotubes, was exclusively cytosolic. Recombinant green fluorescent protein-SLIM1 localized to the cytoplasm and associated with focal adhesions and actin filaments in COS-7 cells, while green fluorescent protein-SLIMMER was predominantly nuclear. SLIMMER truncation mutants revealed that the first nuclear localization signal mediates nuclear localization. The addition of the proposed nuclear export sequence decreased the level of exclusively nuclear expression and increased cytosolic SLIMMER expression in COS-7 cells. The leucine-rich nuclear export signal was required for the export of SLIMMER from the nucleus of myoblasts to the cytoplasm of myotubes. Collectively, these results suggest distinct roles for SLIM1 and SLIMMER in focal adhesions and nuclear-cytoplasmic communication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480922     DOI: 10.1074/jbc.274.38.27083

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.

Authors:  Yuanhong Xu; Zhe Liu; Kejian Guo
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

2.  Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.

Authors:  Elizabeth Vafiadaki; Demetrios A Arvanitis; Vasiliki Papalouka; Gerasimos Terzis; Theodoros I Roumeliotis; Konstantinos Spengos; Spiros D Garbis; Panagiota Manta; Evangelia G Kranias; Despina Sanoudou
Journal:  FEBS J       Date:  2014-06-11       Impact factor: 5.542

3.  Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.

Authors:  Anna Sarkozy; Christian Windpassinger; Judith Hudson; Charlotte F Dougan; Bryan Lecky; David Hilton-Jones; Michelle Eagle; Richard Charlton; Rita Barresi; Hanns Lochmüller; Kate Bushby; Volker Straub
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

4.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

5.  Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.

Authors:  Joachim Schessl; Ana L Taratuto; Caroline Sewry; Roberta Battini; Steven S Chin; Baijayanta Maiti; Alberto L Dubrovsky; Marcela G Erro; Graciela Espada; Monica Robertella; Maria Saccoliti; Patricia Olmos; Leslie R Bridges; Peter Standring; Ying Hu; Yaqun Zou; Kathryn J Swoboda; Mena Scavina; Hans-Hilmar Goebel; Christina A Mitchell; Kevin M Flanigan; Francesco Muntoni; Carsten G Bönnemann
Journal:  Brain       Date:  2009-01-29       Impact factor: 13.501

6.  Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.

Authors:  Ruben Pio; David Blanco; Maria Jose Pajares; Elena Aibar; Olga Durany; Teresa Ezponda; Jackeline Agorreta; Javier Gomez-Roman; Miguel Angel Anton; Angel Rubio; Maria D Lozano; Jose M López-Picazo; Francesc Subirada; Tamara Maes; Luis M Montuenga
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

7.  Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.

Authors:  Lucie Gueneau; Anne T Bertrand; Jean-Philippe Jais; Mustafa A Salih; Tanya Stojkovic; Manfred Wehnert; Maria Hoeltzenbein; Simone Spuler; Shinji Saitoh; Annie Verschueren; Christine Tranchant; Maud Beuvin; Emmanuelle Lacene; Norma B Romero; Simon Heath; Diana Zelenika; Thomas Voit; Bruno Eymard; Rabah Ben Yaou; Gisèle Bonne
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

8.  Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.

Authors:  Joachim Schessl; Yaqun Zou; Meagan J McGrath; Belinda S Cowling; Baijayanta Maiti; Steven S Chin; Caroline Sewry; Roberta Battini; Ying Hu; Denny L Cottle; Michael Rosenblatt; Lynn Spruce; Arupa Ganguly; Janbernd Kirschner; Alexander R Judkins; Jeffrey A Golden; Hans-Hilmar Goebel; Francesco Muntoni; Kevin M Flanigan; Christina A Mitchell; Carsten G Bönnemann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.

Authors:  Edoardo Malfatti; Montse Olivé; Ana Lía Taratuto; Pascale Richard; Guy Brochier; Marc Bitoun; Lucie Gueneau; Pascal Laforêt; Tanya Stojkovic; Thierry Maisonobe; Soledad Monges; Fabiana Lubieniecki; Gabriel Vasquez; Nathalie Streichenberger; Emmanuelle Lacène; Maria Saccoliti; Bernard Prudhon; Marilena Alexianu; Dominique Figarella-Branger; Joachim Schessl; Carsten Bonnemann; Bruno Eymard; Michel Fardeau; Gisèle Bonne; Norma Beatriz Romero
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

10.  An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.

Authors:  Christian Windpassinger; Benedikt Schoser; Volker Straub; Sonja Hochmeister; Abdul Noor; Birgit Lohberger; Natalie Farra; Erwin Petek; Thomas Schwarzbraun; Lisa Ofner; Wolfgang N Löscher; Klaus Wagner; Hanns Lochmüller; John B Vincent; Stefan Quasthoff
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.